Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Allergy and Asthma Proceedings|August 4, 2012
Urinary fluticasone propionate-17beta-carboxylic acid to assess asthma therapy adherenceJohn B Hagan, Brian C Netzel, Marc R Matthews, et al.Mayo Clinic Proceedings|January 6, 2009
Incidence and temporal trends of primary immunodeficiency: a population-based cohort studyAvni Y Joshi, Vivek N Iyer, John B Hagan, et al.The American Journal of Emergency Medicine|November 7, 2015
Appropriateness of epinephrine use in ED patients with anaphylaxisDamian V Baalmann, John B Hagan, James T C Li, et al.Steroids|November 4, 2009
Liquid chromatography-tandem mass spectrometry analysis of urinary fluticasone propionate-17beta-carboxylic acid for monitoring compliance with inhaled-fluticasone propionate therapyNichole L Korpi-Steiner, Brian C Netzel, Jesse C Seegmiller, et al.Human Immunology|February 17, 2010
Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B-A181E mutations in common variable immunodeficiencyXiangyang Dong, Michelle V Hoeltzle, John B Hagan, et al.Allergy and Asthma Proceedings|June 25, 2015
Stepping down inhaled corticosteroids from scheduled to as needed in stable asthma: Systematic review and meta-analysisMichael R Gionfriddo, John B Hagan, Christina R Hagan, et al.Allergy and Asthma Proceedings|April 1, 2009
Elevated serum immunoglobulin E (IgE): when to suspect hyper-IgE syndrome-A 10-year pediatric tertiary care center experienceAvni Y Joshi, Vivek N Iyer, Thomas G Boyce, et al.Journal of the American College of Radiology : JACR|March 19, 2023
Clinical Follow-up in Patients With Moderate or Severe Allergic-Like Reactions to Iodinated Contrast MaterialJennifer S McDonald, Nicholas B Larson, John B Hagan, et al.The Journal of Allergy and Clinical Immunology. in Practice|July 14, 2016
Prospective Validation of the NIAID/FAAN Criteria for Emergency Department Diagnosis of AnaphylaxisCaitlin E Loprinzi Brauer, Megan S Motosue, James T Li, et al.Journal of Clinical Immunology|May 11, 2010
Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiencyJohn B Hagan, Mary B Fasano, Sheldon Spector, et al.Pageof 5